Visiongain has published a new report entitled Internet of Medical Things (IoMT) Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): Forecasts by Component (Hardware, Software, Services), by Deployment (On-premises, Cloud), by Application (Telemedicine, Clinical Operations & Workflow Management, Connected Imaging, Medication Management, Inpatient Monitoring, Others), by End-users (Homecare, Clinics, Hospitals, Research Institutes & Academics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies.

The global internet of medical things (IoMT) market is estimated at US$175.8 billion in 2025 and is projected to grow at a CAGR of 19.6% during the forecast period 2025-2035.

Impact of US Trade Tariffs on the Global Internet of Medical Things (IoMT) Market  

The introduction or escalation of U.S. trade tariffs has far-reaching implications for the global IoMT ecosystem. At the core of this disruption is the heavy reliance on imported components—such as microchips, connectivity modules, and diagnostic sensors—which are integral to the functionality of IoMT devices. Tariffs on these imports, particularly from countries like China, significantly raise input costs, which can cascade through the value chain and result in more expensive end-products.

Beyond rising costs, tariffs introduce strategic and logistical complexities. IoMT manufacturers and assemblers may be forced to reassess sourcing strategies, reconfigure supply chains, or shift production bases to mitigate tariff exposure. This reallocation process often results in longer lead times, increased regulatory hurdles, and short-term inefficiencies that can slow down innovation and market responsiveness.

Additionally, the ripple effect of tariffs may lead to price volatility, especially for small- and mid-sized players who lack the financial resilience to absorb abrupt cost hikes. For hospitals and care providers in developing regions, this could mean limited access to cutting-edge IoMT technologies, thus widening the global digital health gap.

While tariffs may prompt long-term investments in regional manufacturing or R&D localisation, the immediate effect is one of market fragmentation and operational uncertainty. For a market as interdependent and innovation-driven as IoMT, such trade policy actions present a considerable barrier to scalable, equitable growth.

Revolutionising Healthcare with IoMT: Enabling Remote Monitoring and Advancing Value-Based Care

The healthcare sector is experiencing a significant transformation, propelled by the integration of digital advancements and medical innovation. Central to this evolution is the Internet of Medical Things (IoMT), a rapidly growing network of smart medical devices, software platforms, and healthcare systems that interact effortlessly through internet connectivity. These devices function autonomously, enabling the real-time exchange of vital health information without the need for direct human involvement.

One of the most impactful applications of IoMT is in remote patient monitoring (RPM). Through wearable sensors and home-based diagnostic tools, clinicians can now monitor vital signs, track chronic disease progression, and adjust treatments without the patient needing to visit a healthcare facility. Devices such as smart glucose meters, ECG monitors, pulse oximeters, digital stethoscopes, and connected blood pressure cuffs are transforming how care is delivered—bringing it closer to the patient, both physically and temporally.

In addition to enhancing convenience, the adoption of IoMT is closely aligned with the global movement toward value-based healthcare, where compensation is linked to patient outcomes instead of service volume. Through real-time, continuous data sharing, IoMT enables healthcare providers to take early action, customise treatment plans more effectively, lower hospital readmission rates, and boost long-term patient health. This approach benefits all stakeholders—patients gain access to more personalised and preventive care, insurers experience cost reductions, and providers can manage resources with greater efficiency.

Building on this, predictive analytics powered by IoMT platforms are becoming increasingly vital. Leveraging artificial intelligence and machine learning, healthcare systems are now able to forecast potential complications, streamline the use of medical resources, and customise treatments to individual needs. For instance, smart beds and fall-detection systems can issue early warnings, allowing clinical staff to respond proactively and improve patient safety significantly.

The impact of IoMT also extends to clinical trials and research. With decentralised trials gaining traction, IoMT devices allow investigators to collect accurate, real-world data from diverse populations, enhancing both the speed and validity of trials.

Despite these benefits, challenges remain—including data privacy concerns, interoperability issues, and regulatory hurdles. However, increasing investments in cybersecurity, advancements in data standards, and supportive regulatory frameworks are gradually addressing these barriers.

How will this Report Benefit you?

Visiongain’s 287-page report provides 101 tables and 192 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the internet of medical things (IoMT) market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for Internet of Medical Things (IoMT). Get financial analysis of the overall market and different segments including type, process, upstream, downstream, and company size and capture higher market share. We believe that there are strong opportunities in this fast-growing internet of medical things (IoMT) market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report will help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.

What are the Current Market Drivers?

Enhanced Patient Monitoring and Personalised Care

The incorporation of IoT-enabled technologies is transforming how patients are monitored, offering real-time, continuous tracking of vital signs, medication intake, and other critical health indicators. Wearable technologies—including smartwatches, fitness trackers, and specialised medical sensors—empower individuals to monitor parameters such as heart rate, blood pressure, oxygen levels, and glucose levels from their homes. This data is automatically relayed to healthcare professionals, enabling prompt clinical decisions and reducing the likelihood of serious health events.

Remote monitoring is particularly beneficial for seniors, patients with chronic illnesses, and post-operative individuals who may find frequent hospital visits challenging. Devices like Apple Watches and Fitbits can detect abnormal changes in activity or heart rate, allowing early interventions. For instance, researchers at Stanford University are developing algorithms that analyse heart rate fluctuations to identify early signs of infection or delayed healing, shifting healthcare toward a more proactive and preventive model.

Moreover, aspects like the thickness of Printed Circuit Boards (PCBs) are gaining importance in the design of wearables, as they impact both the comfort and usability of devices—factors critical to sustained patient engagement and effective long-term health tracking.

Improved Diagnostics and Proactive Treatment

The role of IoMT extends beyond monitoring to enhance the accuracy and efficiency of medical diagnostics. Connected diagnostic tools—such as digital stethoscopes, ECG monitors, blood pressure devices, and blood glucose meters—automatically collect and transmit data to physicians, enabling longitudinal tracking of health conditions.

By aggregating and analysing health data over time, healthcare professionals can detect trends, identify early warning signs, and personalise treatment plans with greater precision. For instance, an IoT-enabled glucose monitor worn by a diabetic patient can continuously measure blood sugar levels and share the data with their care team. If abnormal patterns are detected—such as a spike indicative of hyperglycemia or a sudden drop suggestive of hypoglycemia—alerts can be triggered for both the patient and physician, enabling swift corrective action before the condition becomes life-threatening.

This level of automation and immediacy in diagnostics supports the transition from reactive to preventive and predictive healthcare, improving patient outcomes while reducing hospital admissions and associated costs.

Where are the Market Opportunities?

Smart Pills: Pioneering Internal Monitoring in Connected Healthcare

The advent of smart pills represents a significant innovation in the evolving landscape of digital healthcare and medical monitoring. These ingestible capsules are embedded with miniature sensors that, once swallowed, transmit real-time physiological data from within the body. Upon reaching the gastrointestinal tract, these pills can relay critical metrics such as core body temperature, respiratory rate, and heart rate.

An emerging example is Celero Systems, a digital health company currently developing an electronic pill designed to monitor vital signs directly from the stomach. Initially intended for chronic disease management in home-care settings, the long-term goal is to employ this technology as an internal alert system, potentially capable of detecting early signs of drug overdoses or fatal complications before they escalate. This innovation highlights a new dimension of non-invasive, real-time monitoring, allowing physicians and caregivers to receive actionable data with unprecedented accuracy.

Facilitating Elderly Care Through IoMT-Enabled Remote Monitoring

The elderly population is among the primary beneficiaries of IoMT-based solutions, particularly given the challenges many face in adapting to conventional digital technologies. While a significant portion of senior individuals remain inclined toward traditional healthcare methods, their increased vulnerability to chronic illnesses and age-related complications necessitates ongoing health supervision.

IoMT-powered devices tailored for geriatric care offer an effective solution. These tools can track vital signs, send automated medication and dietary reminders, and alert caregivers in case of anomalies or emergencies. By minimising the need for frequent hospital visits—which can be physically taxing for the elderly—IoT-enabled monitoring ensures that seniors receive timely, convenient, and comprehensive care within their own homes. This approach not only promotes patient comfort and independence but also reduces the burden on healthcare infrastructure and family caregivers.

Competitive Landscape

The major players operating in the internet of medical things (IoMT) market are Baxter (Hill-Rom Services, Inc.), Bio Techne Corp, Biotronik, Boston Scientific Corporation, Cisco Systems, Inc., GE Healthcare, IBM Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic, and Siemens. These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.

Recent Developments

• On 27th February 2025,  Kajeet®, announced its selection as a Cisco Select Partner, joining forces to deliver a high-performance Private 5G Managed Service with Cisco’s Private 5G management platform to efficiently manage the private 5G network and Kajeet’s neutral host networks designed to solve in-building connectivity challenges for hospitals and healthcare systems.
• On 13th November 2024, NEC X, the innovation accelerator of NEC Corporation, announced its investment in General Prognostics Inc. (GPx), a MedTech startup advancing AI-based heart health monitoring. GPx is developing CardioID, a non-invasive, wearable-powered solution that leverages machine learning to predict heart failure events. 
• On 20th March 2024, – Onymos, and Vapotherm, Inc.  announced the formation of a development and commercialization partnership. This partnership will help Vapotherm create a unique respiratory digital platform to meet its data visualization and device management goals for the Vapotherm HVT® 2.0 system in the acute care space as well as for future products in the home.

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to contactus@visiongain.com or call +44 207 336 6100.

About Visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.